Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 27-Feb-24 4:24 PM View:  | Vertex Pharmaceuticals Inc. (VRTX) | 26-Feb-24 | Sale (Planned) | 4,239 | $425.70 | $1,804,540.00 | (14%) 30.05K to 25.81K | |
| 27-Feb-24 4:24 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 23-Feb-24 | Payment of Exercise | 3,970 | $431.79 | $1,714,210.00 | (12%) 34.02K to 30.05K | |
| 23-Feb-24 4:10 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 21-Feb-24 | Private Sale (Planned) | 3,002 | $421.77 | $1,266,150.00 | (8%) 37.02K to 34.02K | |
| 21-Feb-24 4:13 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 20-Feb-24 | Payment of Exercise | 2,812 | $420.58 | $1,182,670.00 | (6%) 43.84K to 41.03K | |
| 21-Feb-24 4:13 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 20-Feb-24 | Sale (Planned) | 4,002 | $420.79 | $1,684,000.00 | (10%) 41.03K to 37.02K | |
| 21-Feb-24 4:13 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-Feb-24 | Payment of Exercise | 3,750 | $424.01 | $1,590,040.00 | (8%) 47.59K to 43.84K | |
| 13-Feb-24 4:46 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 12-Feb-24 | Sale (Planned) | 3,145 | $420.24 | $1,321,650.00 | (6%) 50.73K to 47.59K | |
| 13-Feb-24 4:46 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 09-Feb-24 | Payment of Exercise | 2,099 | $422.74 | $887,331.00 | (4%) 52.83K to 50.73K | |
| 08-Feb-24 4:10 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Feb-24 | Grant | 7,114 | -- | -- | 16% 45.72K to 52.83K | |
| 08-Feb-24 4:10 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Feb-24 | Grant | 13,680 | -- | -- | 43% 32.04K to 45.72K | |
| 17-Nov-23 4:11 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-Nov-23 | Private Sale (Planned) | 19 | $369.92 | $7,028.48 | (< 1%) 32.06K to 32.04K | |
| 11-Aug-23 4:05 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 09-Aug-23 | Private Sale (Planned) | 63 | $345.51 | $21,767.10 | (< 1%) 32.1K to 32.04K | |
| 28-Feb-23 4:40 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 27-Feb-23 | Sale (Planned) | 4,238 | $287.51 | $1,218,450.00 | (12%) 36.28K to 32.04K | |
| 28-Feb-23 4:40 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-23 | Payment of Exercise | 3,970 | $289.12 | $1,147,810.00 | (10%) 40.25K to 36.28K | |
| 22-Feb-23 4:25 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 21-Feb-23 | Sale (Planned) | 4,002 | $293.77 | $1,175,680.00 | (9%) 44.25K to 40.25K | |
| 22-Feb-23 4:25 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-23 | Payment of Exercise | 3,750 | $292.85 | $1,098,190.00 | (8%) 48.0K to 44.25K | |
| 16-Feb-23 4:11 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 14-Feb-23 | Private Sale (Planned) | 6,398 | $298.70 | $1,911,110.00 | (12%) 54.4K to 48.0K | |
| 14-Feb-23 4:49 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Feb-23 | Payment of Exercise | 5,990 | $298.26 | $1,786,580.00 | (9%) 65.18K to 59.19K | |
| 14-Feb-23 4:49 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Feb-23 | Sale (Planned) | 4,798 | $298.90 | $1,434,130.00 | (8%) 59.19K to 54.4K | |
| 14-Feb-23 4:49 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-23 | Payment of Exercise | 3,461 | $294.33 | $1,018,680.00 | (5%) 68.64K to 65.18K | |
| 08-Feb-23 4:53 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Feb-23 | Option Exercise | 1,304 | $187.53 | $244,539.00 | 2% 68.64K to 69.95K | (10%) |
| 08-Feb-23 4:53 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Feb-23 | Planned Private Option Sale | 1,304 | $306.00 | $399,022.00 | (2%) 69.95K to 68.64K | |
| 03-Feb-23 4:30 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-23 | Grant | 32,568 | -- | -- | 90% 36.08K to 68.64K | |
| 17-Nov-22 4:08 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-Nov-22 | Private Sale (Planned) | 34 | $308.61 | $10,492.70 | (< 1%) 36.11K to 36.08K | |
| 09-Nov-22 4:40 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Nov-22 | Option Exercise | 1,303 | $187.53 | $244,352.00 | 4% 36.08K to 37.38K | (10%) |
| 09-Nov-22 4:40 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Nov-22 | Planned Private Option Sale | 1,303 | $303.04 | $394,859.00 | (3%) 37.38K to 36.08K | |
| 10-Aug-22 4:06 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 08-Aug-22 | Option Exercise | 1,304 | $187.53 | $244,539.00 | 4% 36.08K to 37.38K | (10%) |
| 10-Aug-22 4:06 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 08-Aug-22 | Planned Private Option Sale | 1,304 | $292.54 | $381,469.00 | (3%) 37.38K to 36.08K | |
| 21-Jul-22 4:48 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 19-Jul-22 | Option Exercise | 17,765 | $174.33 | $3,096,950.00 | 49% 36.18K to 53.94K | (3%) |
| 21-Jul-22 4:48 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 19-Jul-22 | Planned Private Option Sale | 17,765 | $288.65 | $5,127,860.00 | (33%) 53.94K to 36.18K | |
| 21-Jul-22 4:48 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 19-Jul-22 | Sale (Planned) | 100 | $288.65 | $28,865.00 | (< 1%) 36.18K to 36.08K | |
| 28-Feb-22 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 25-Feb-22 | Sale (Planned) | 7,572 | $230.98 | $1,748,990.00 | (17%) 43.65K to 36.08K | |
| 28-Feb-22 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-22 | Payment of Exercise | 6,038 | $227.86 | $1,375,820.00 | (12%) 49.69K to 43.65K | |
| 22-Feb-22 4:51 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 18-Feb-22 | Sale (Planned) | 4,312 | $230.97 | $995,949.00 | (8%) 54.0K to 49.69K | |
| 22-Feb-22 4:51 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-22 | Payment of Exercise | 3,439 | $232.51 | $799,602.00 | (6%) 57.44K to 54.0K | |
| 16-Feb-22 4:05 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 14-Feb-22 | Private Sale (Planned) | 2,444 | $232.02 | $567,057.00 | (4%) 59.88K to 57.44K | |
| 14-Feb-22 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 11-Feb-22 | Sale (Planned) | 2,297 | $235.02 | $539,837.00 | (4%) 62.18K to 59.88K | |
| 14-Feb-22 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-22 | Payment of Exercise | 3,518 | $237.74 | $836,369.00 | (5%) 65.7K to 62.18K | |
| 03-Feb-22 4:06 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Feb-22 | Option Exercise | 4,660 | $86.52 | $403,183.00 | 7% 65.7K to 70.36K | |
| 03-Feb-22 4:06 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Feb-22 | Planned Option Sale | 4,660 | $251.47 | $1,171,840.00 | (7%) 70.36K to 65.7K | |
| 03-Feb-22 4:06 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-22 | Grant | 32,108 | -- | -- | 96% 33.59K to 65.7K | |
| 16-Nov-21 4:04 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-Nov-21 | Private Sale (Planned) | 34 | $187.22 | $6,365.40 | (< 1%) 33.62K to 33.59K | |
| 19-May-21 4:02 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-May-21 | Private Sale (Planned) | 79 | $216.36 | $17,092.80 | (< 1%) 33.67K to 33.59K | |
| 26-Feb-21 4:03 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 25-Feb-21 | Sale (Planned) | 3,028 | $213.39 | $646,139.00 | (8%) 36.62K to 33.59K | |
| 26-Feb-21 4:03 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-21 | Payment of Exercise | 2,416 | $217.57 | $525,649.00 | (6%) 39.03K to 36.62K | |
| 19-Feb-21 4:05 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 18-Feb-21 | Sale (Planned) | 7,825 | $211.83 | $1,657,590.00 | (17%) 46.86K to 39.03K | |
| 19-Feb-21 4:05 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-21 | Payment of Exercise | 6,240 | $211.75 | $1,321,320.00 | (12%) 53.1K to 46.86K | |
| 16-Feb-21 4:02 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 11-Feb-21 | Private Sale (Planned) | 5,283 | $210.54 | $1,112,270.00 | (9%) 58.38K to 53.1K | |
| 12-Feb-21 4:02 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-21 | Payment of Exercise | 2,974 | $214.16 | $636,912.00 | (5%) 61.35K to 58.38K | |
| 05-Feb-21 4:42 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Feb-21 | Grant | 32,453 | -- | -- | 112% 28.9K to 61.35K |